[Cefroxadine preparation].
D000328:Adult; D000818:Animals; D001419:Bacteria / Q000187:drug effects; D002214:Capsules; D002511:Cephalosporins / Q000633:toxicity; D002515:Cephradine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000378:metabolism / Q000633:toxicity; D055598:Chemical Phenomena; D002621:Chemistry; D004352:Drug Resistance, Microbial; D004355:Drug Stability; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D012098:Reproduction / Q000187:drug effects
D002214:Capsules; D002511:Cephalosporins; C012671:cefroxadine; D002515:Cephradine